Selective exclusion of treatment arms in multi-arm randomized clinical trials

Statistics in Medicine

Volumn 22, Issue 1, 2003, Pages 19-30

  Law, Matthew G ^a   Emery, Sean ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Design; Randomized clinical trial; Sample size

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; CALCIUM ANTAGONIST; DIDANOSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; BIOSTATISTICS; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EXPERIMENTAL DESIGN; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; PATIENT MONITORING; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STATISTICAL ANALYSIS;

DATA INTERPRETATION, STATISTICAL; HUMANS; PATIENT SELECTION; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 0037438659     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1308     Document Type: Article

References (9)

1. Alpha International Coordinating Committee. The Alpha trial: European/Australian randomized double-blind trial of two doses of didanosine in zidovudine-intolerant patients with symptomatic HIV disease. AIDS 1996; 10: 867-880.
2. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone - The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Journal of the American Medical Association 2000; 283:1967-1975.
3. U.K. Medical Research Council Clinical Trials Unit. http://www.ctu.mrc.ac.uk/hiv_division/hiv_trials.asp.
4. Pocock SJ. Clinical Trials: a Practical Approach. Wiley: Chichester, 1983.
5. D'Agostino RB, Heeren TC. Multiple comparisons in over-the-counter drug clinical trials with both positive and placebo controls (with comments and rejoinder). Statistics in Medicine 1991; 10:1-31.
6. Dunnett CW, Tambane AC. Comparisons between a new drug and active and placebo controls in an efficacy clinical trial. Statistics in Medicine 1992; 11:1057-1063.
7. Gore SM. The consumer principle of randomization. Lancet 1994; 343:58.
8. Byar DP. Factorial and reciprocal control designs. Statistics in Medicine 1990; 9:55-64.
9. Byar DP, Herzberg AM, Tan W-Y. Incomplete factorial designs for randomized clinical trials. Statistics in Medicine 1993; 12:1629-1641.